Related Experiment Video
Updated: Jan 29, 2026

09:35
Neurodevelopmental Reflex Testing in Neonatal Rat Pups
Published on: April 24, 2017
21.0K
Artificial Womb Technology for Extremely Premature Neonates: Preclinical Neurodevelopmental Outcomes
Felix R De Bie1, Chelsea J Zhang1, Sharla M Rent2
1Department of Surgery, Division of Pediatric Surgery, Duke University, Durham, NC 27705, USA.
Children (Basel, Switzerland)
|January 28, 2026
Summary
Extreme prematurity (22-24 weeks) poses significant neurological risks. Artificial womb technology shows promise for improving neurodevelopmental outcomes in extremely preterm infants, with ongoing preclinical research.
Area of Science:
- Neonatal neurology
- Developmental neuroscience
- Bioengineering
Background:
- Extreme prematurity (22-24 weeks gestation) is associated with severe neurological and neurodevelopmental challenges.
- Current neonatal intensive care unit (NICU) survival rates for these infants remain limited, with significant long-term morbidities.
- There is a critical need for novel therapeutic strategies to improve outcomes for extremely preterm infants.
Purpose of the Study:
- To review current neurological and neurodevelopmental outcomes in infants born between 22 and 24 weeks of gestational age.
- To explore the scientific and clinical rationale for developing artificial womb technology.
- To provide an overview of the state-of-the-art in preclinical artificial womb models and analyze their neurological outcomes.
Main Methods:
- Narrative review of existing literature on extreme prematurity outcomes.
- Analysis of preclinical artificial womb models, focusing on structural, developmental, and functional neurological assessments.
- Evaluation of the limitations of current preclinical models for clinical translation.
Main Results:
- Infants born at 22-24 weeks face high risks of adverse neurological and neurodevelopmental sequelae.
- Preclinical artificial womb models demonstrate potential for supporting development, with varying degrees of success in mimicking intrauterine conditions.
- Neurological outcomes in preclinical models show promise but require further refinement to address limitations.
Conclusions:
- Artificial womb technology represents a potential paradigm shift in managing extreme prematurity.
- Further research and development of preclinical models are essential to optimize neurological outcomes before clinical application.
- Addressing the limitations of current artificial womb technology is crucial for successful clinical translation and improving survival and neurodevelopment in extremely preterm infants.
More Related Videos
Related Concept Videos
Predicting Reaction Outcomes
10.8K
Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...
10.8K
Outcomes of Glycolysis
107.1K
Nearly all the energy used by cells comes from the bonds that make up complex organic compounds. These organic compounds are broken down into simpler molecules, such as glucose. As a result, cells extract energy from glucose over many chemical reactions—a process called cellular respiration.
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
107.1K
Absolute and Local Extreme Values
63
The highest and lowest values of a function, relative to a reference axis, are known as extreme values. These include absolute maximum and absolute minimum values, which represent the highest and lowest points the function reaches across its entire domain. Within a restricted portion of the function, the highest and lowest values are referred to as local maximum and local minimum values, respectively.Periodic functions, such as sine and cosine, show extreme values at infinitely many points due...
63
Guidelines for Writing Outcome
3.8K
When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
3.8K
Preclinical Development: Overview
5.9K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.9K
Hybridoma Technology
17.6K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
17.6K

